There is a wide body of evidence to suggest the existence of at least three distinct opioid receptor types in the CNS, referred to as ~, 6, and K. This paper reviews some of the findings that have led to this conclusion and the anatomical distributions of these sites in the rat brain. Their relation to the opioid peptides and some of the proposed functions mediated by these receptor systems are also discussed.
Largely because of their clinical significance and recent technological advances, the opioid systems are among the best understood peptide systems in the CNS. While it is difficult to pinpoint precisely what has caused this interest, it is clear that the key elements included the discovery of opioid peptides in the CNS 1, the description of their genes, mRNAs and precursors z-4, the characterization of their receptors 5, and the finding that these pepfides are released following certain forms of stimulation s . Since it is well beyond the scope of this paper to review this field comprehensively, we have chosen to concentrate our efforts on the anatomical distribution of the opioid receptors in the CNS and their relationships with the opioid pepfide systems. Having presented this anatomical information, we will then discuss some of the functions thought to be mediated by these multiple receptors.
Historically, the discovery of opioid receptors 7 preceded the isolation and characterization of the opioid peptides. Once we knew of only one opiate receptor -now there have been suggestions of as many as nine 8-12. This review will focus on the three widely accepted opioid receptor types which are referred to as Iz, 6 and K, and will discuss their possible interactions with the pro-opiomelanocortin (POMC), pro-enkephalin and pro-dynorphin pepfide systems.
Several lines of evidence support the existence of multiple opioid receptors. One of the earliest findings to suggest this multiplicity was the demonstration by Martin and his colleagues 13 that different classes of opiate drugs produced distinct behavioral syndromes and that tolerance to one group of opiates did not result in cross-tolerance to another class of opiate drugs. On the basis of these findings, Martin and his colleagues proposed the existence of three types of opioid receptors: ~ for morphine-like compounds, i< for ketocyclazocine-like drugs and o for drugs such as SKF 10,047. Further support for this position came from studies using peripheral organ bioassays where the relative potencies of several opioids and opiate antagonists varied with tissue system 14, again suggesting a heterogeneity of receptors. In addition, investigators using these tissue systems suggested the existence of yet another receptor type, referred to as 6, named for the mouse vas deferens bioassay, where enkephalin peptides were found to be particularly potent b. The findings from these early pharmacological experiments were further supported Fig. 1 
